RxDoctor Payments Data

Mariannette Plaza, NP

Nurse Practitioner · Davenport, FLNPI 1477535144

Payments from drug & device makers

$825in general payments, 2019–2025

Across 41 payments — averaging $20.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$148
  • Novo Nordisk$134
  • Lilly USA, LLC$125
  • AbbVie$87
  • Exact Sciences$60
  • GSK$52
  • plus $219 from 8 others

What the payments were for

  • Food & beverage$825100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$825 in reported general payments places this provider in the 70th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Medicare billing

Part B allowed, 2024
$12,385
Medicare patients
41
Services billed
208

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin76$96,246
EliquisApixaban57$64,228
OzempicSemaglutide35$33,742
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$13,019
Atorvastatin Calcium540$4,551
Albuterol Sulfate HfaAlbuterol Sulfate153$3,554
LantusInsulin Glargine,hum.Rec.Anlog27$3,433
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$3,375
SymbicortBudesonide/Formoterol Fumarate11$3,100
Gabapentin175$2,652
Ezetimibe94$2,440
Novolin 70-30Insulin Nph Hum/Reg Insulin Hm11$2,414
Losartan Potassium306$2,334
BreynaBudesonide/Formoterol Fumarate15$2,276
Levothyroxine Sodium235$2,192

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$148$96,24676 claims
Novo NordiskOzempic$134$33,74235 claims
GSKTrelegy Ellipta$52$13,01915 claims
AstraZenecaSymbicort$50$3,10011 claims
AbbVieSynthroid$87$2,09321 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Davenport

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →